Team

Barak Singer

VP Business Development, Trendlines Medical

Barak Singer has over 15 years of experience in management, business development, investment banking, and venture capital.

Prior to joining Trendlines, Barak held a number of senior management positions, including Managing Director, Co-Head of Investment Banking, and Head of Healthcare at Tamir Fishman & Co., representing the Royal Bank of Canada’s (NYSE:RY) investment banking arm in Israel, RBC Capital Markets. He also served as VP Business Development at Can-Fite BioPharma (NYSE: CANF) and CEO of its subsidiary Ophthalix, VP Business Development at Xenia Venture Capital, and was a Co-Founder and CEO at Or Capital Healthcare Partners.

Barak received his LLB and BA in business (both with distinction) from the Interdisciplinary Center in Herzliya, Israel.

Yuval Almougy

VP New Ventures, Trendlines Medical

Yuval Almougy brings over 15 years of experience in business development, project management, and funding.

Prior to joining Trendlines, Yuval founded and managed a medical device accelerator, and served as Director of Business Development of Shizim Group, where he was responsible for assessing feasibility and the potential of new initiatives, including carrying out due diligence on investment opportunities. He also took an active role in leading and supporting new ventures.

Previously, he served as Project Management Director of Sunrise Projects (now FreeMind), which is the leading expert-based granting consultancy in Israel for high-tech ventures. Before that, he worked as project manager at Earthnoise, a video broadcasting and sharing platform start-up, and at Adkit, an international business and marketing information company, where he headed the Market Research department.

Yuval holds an MBA from Tel Aviv University, Master of Industrial Design (with a focus on medical and social design) from the Technion-Israel Institute of Technology, and a BA in business management and communications from The Hebrew University of Jerusalem.

Sarai Kemp

VP Business Development, Trendlines Agtech

As VP Business Development for Trendlines Agtech since 2012, Sarai Kemp is responsible for directing the business and financial development and fund-raising strategies and activities for early-stage portfolio companies developing innovative technologies and products in aquaculture, crop protection, precision ag, foodtech, and other related sectors.

Trendlines Agtech is part of The Trendlines Group. Trendlines invents, discovers, invests in, and incubates innovation-based medical and agricultural technologies, and is involved in all aspects of its portfolio companies from technology development to business building.

Sarai brings more than 18 years’ experience in agricultural, consumer goods, and high-tech industries, including in sales, marketing, and business development for international companies such as Afimilk and Keter Plastic. She has worked intensively with companies in East Asia.

Sarai received an MBA from Haifa University and a B.A. from Tel Aviv University.

Maya Schushan Orgad, PhD

VP Bayer Trendlines Ag Innovation Fund, VP Trendlines Agtech

Maya Schushan Orgad brings over six years of multidisciplinary experience that combines a broad science and technology background with project management, strategy, and business development.

Prior to joining Trendlines, Maya led entry into new areas of activities at Evogene, a leading, publicly traded biotech company involved in agtech, in which she served as director of business development. As part of her role, she identified new business opportunities, formulated business plans and entry strategies, led fundraising via grants, performed technology scouting efforts, and established multiple strategic collaboration deals with 1st tier agriculture companies.

Previously, she completed a PhD in computational biology in the Biochemistry & Molecular Biology Department at the Life Sciences Faculty of Tel Aviv University, graduating magne cum laude. Her PhD consisted of multiple international collaborative research projects in Israel and abroad, resulting in 10 publications in top-tier journals.

She also served as a scientific consultant in the Life Science Faculty Bioinformatics Unit, leading consulting research projects and workshops for both academia and industry. She received her MBA in Technology, Entrepreneurship and Innovation and a BSc in life sciences, both from Tel Aviv University.

Nir Goldenberg

VP Business Development Trendlines Labs

Nir Goldenberg brings extensive experience in business development, sales, and marketing in the medical device sector.

At Trendlines Labs, Nir oversees the business development activities of the in-house innovation center, which evaluates critical unmet clinical needs, innovates technological solutions, and provides proof of concept and program risk mitigation at an early stage of development.

Prior to starting his work at Trendlines Labs, Nir served as Director of Commercial Development EU at INSIGHTEC Ltd., a global MR-guided focused ultrasound surgery company.

Nir holds a BSc in engineering from La Sapienza University of Rome.

Avshalom Shenhav, PhD

CTO, Trendlines Labs

Avshalom Shenhav has over 20 years of experience in the medical device field.

Prior to joining Trendines, Avshalom was part of the Physics Group at Biosense Webster (a J&J company), in the MRI Division of Elscint (purchased by GE), in KLA (semiconductor industry), and as part of a number of start-ups. He has served as an algorithm developer, physiological model researcher, magnetic field analyzer, and system integrator.

At Trendines Labs, Avshalom is responsible for the concept development, clinical needs studies, and developing detailed algorithms and software.

Avshalom holds a PhD in biomedical engineering and a BSc in electronics engineering, both from the Technion-Israel Institute of Technology.

Lionel Lim

Trendlines Medical Singapore, Director, Business Ventures

Lionel Lim has more than 10 years of experience in project management, strategic marketing, and R&D in the health care sector.

Prior to joining Trendlines Medical Singapore, Lionel was a senior consultant with The Economist Intelligence Unit Healthcare, where he leads projects on growth advisory and commercial due diligence for merger & acquisition for fortune top 500 healthcare companies. He also worked with government agencies in Singapore to validate proof of concept and proof of value for medical devices.

Prior to The Economist, Lionel was a senior research associate at DX Assay, a start-up company which was supported by Economic Development Board Singapore (EDB) and Qiagen with the objective to develop the growth of personalized medicine.

He was also involved as a research associate with the Cancer Science Institute at National University of Singapore and Institute of Bioengineering and Nanotechnology.

Lionel received a BSc biotechnology (Hons) from the University of Queensland, Australia.

Evelynn Chong

Trendlines Medical Singapore, Manager, Finance & Operations

Evelynn Chong has over 10 years of experience in finance, audits, HR, and office operations.

Prior to joining Trendlines Medical Singapore, Evelynn was responsible for finances at D&M Electronics Singapore Pte Ltd. Before joining D&M, she was the pioneer staff at Silecs International Pte Ltd, a start-up venture, where she was responsible for the finance, HR, and operations. Previously, she managed business reporting and compliance at Geo Energy Resources Ltd, a publicly listed company on the Singapore Exchange (SGX).

Evelynn received a BSc (Hons) in business and management studies, with a major in accounting and finance, from the University of Bradford, UK.

Eunice Chew

Trendlines Medical Singapore, Manager, Business Development

Eunice Chew has more than five years of experience working with medical technology start-ups and health care institutions.

Prior to joining Trendlines Medical Singapore, Eunice was a senior manager at Enterprise Singapore, an economic agency of the Singapore government, where she was instrumental in developing initiatives for the biomedical and health care sectors.

She also account-managed a portfolio of more than 40 medical technology start-ups and small and medium enterprises (SMEs), supporting these companies in their commercialization, partnerships, financing, and market access efforts.

Eunice holds an MSc in IP management and a BSc (Hons) in economics from the National University of Singapore.

Shahar Harari

Trendlines Group, CTO

Shahar Harari has extensive technical and management experience with product design and development.

Irit Shemesh Catz

Trendlines Group, Director of Operations

Irit Shemesh-Catz brings more than 25 years of experience in mission-critical operations and business-related management in the high-tech industry.

Prior to joining Trendlines, Irit served as the marketing contracts and engagements manager in the Homeland Security Division of Rafael, Israel’s Advanced Defense Systems, where she was responsible for negotiating terms of engagement for worldwide contracts, including with Rafael’s main subcontractors. Prior to that, she was contract and purchasing manager, handling purchasing contracts and engagements for Rafael’s critical suppliers.

Previously, Irit served as VP business development at Nemic-Lambda Israel, where she was responsible for setting the Company’s strategy in the local market and leading business growth activities, including assessing the feasibility and the potential of new businesses and ventures. Irit also served as VP marketing and sales, leading all marketing and sales activities in Israel.

Irit holds a B.Sc. in industrial engineering and management from the Technion-Israel Institute of Technology and a degree in practical engineering (electronics).

Eddy Wang

Trendlines China Office, Director

As the Director of Trendlines China Office, Eddy introduces Chinese investors and industrial partners to The Trendlines Group, its portfolio companies, and Trendlines Labs; conducts and promotes Trendlines events held in China and in Israel; develops and maintains relationships with key contacts from the private and public sectors in China.

Prior to stating his work in Trendlines, Eddy served as Director of the International Department of HTIBI, which is an international incubator managed by Beijing Science and Technology Commission. He was Sales Manager of the Corporate Clients Division at Air China Northern Distribution and Manager of the Personal Financial Consultant Department of AXA Insurance China and an Experiment Technician of Wild Animal Pathology Institution at the University of Saskatchewan (Canada).

Eddy holds a BSc (honors) in environment studies and GIS (Geography Information System) from the University of Saskatchewan (Canada).